Life sciences work—across transactions, intellectual property and regulatory matters—provided a bright spot in Big Law business in 2020 that firms expect to fuel an even more promising 2021.

The pandemic, in particular, has created an increasing need for regulatory and corporate experts, among others, as companies look to the digital world to innovate and solve unmet needs in health care.